Stéphane Quéré

814 total citations
34 papers, 646 citations indexed

About

Stéphane Quéré is a scholar working on Endocrinology, Diabetes and Metabolism, Transplantation and Surgery. According to data from OpenAlex, Stéphane Quéré has authored 34 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Transplantation and 6 papers in Surgery. Recurrent topics in Stéphane Quéré's work include Diabetes Treatment and Management (8 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Diabetes Management and Research (4 papers). Stéphane Quéré is often cited by papers focused on Diabetes Treatment and Management (8 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Diabetes Management and Research (4 papers). Stéphane Quéré collaborates with scholars based in France, United States and Switzerland. Stéphane Quéré's co-authors include Hassiba Oubraham, G. Mimoun, Salomon Y. Cohen, S. Dejager, Véronique Schneider, Alain Zourdani, B. Fiquet, D. Huet, Alfred Penfornis and Eric H. Souied and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Stéphane Quéré

30 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphane Quéré France	13	215	185	157	125	109	34	646
Hendrik A. van Leiden Netherlands	9	404 1.9×	344 1.9×	155 1.0×	9 0.1×	98 0.9×	14	741
Lois Jovanovič United States	14	18 0.1×	25 0.1×	462 2.9×	9 0.1×	296 2.7×	26	833
R.N. Dalton United Kingdom	10	114 0.5×	79 0.4×	184 1.2×		98 0.9×	17	515
Elizabeth A. Atchison United States	10	165 0.8×	103 0.6×	74 0.5×		47 0.4×	14	566
Andrew Drexler United States	10	89 0.4×	74 0.4×	225 1.4×		59 0.5×	20	430
Elżbieta Bandurska‐Stankiewicz Poland	11	85 0.4×	68 0.4×	222 1.4×		83 0.8×	52	426
Ahmad H. Al‐Sharqawi Saudi Arabia	11	91 0.4×	79 0.4×	313 2.0×		41 0.4×	11	589
Núria Alcubierre Spain	11	128 0.6×	101 0.5×	102 0.6×		19 0.2×	13	377
François Chast France	8	129 0.6×	58 0.3×	49 0.3×		49 0.4×	35	381
Dimitrios Mamoulakis Greece	10	17 0.1×	109 0.6×	183 1.2×	2 0.0×	102 0.9×	17	477

Countries citing papers authored by Stéphane Quéré

Since Specialization

Citations

This map shows the geographic impact of Stéphane Quéré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Quéré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Quéré more than expected).

Fields of papers citing papers by Stéphane Quéré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Quéré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Quéré. The network helps show where Stéphane Quéré may publish in the future.

Co-authorship network of co-authors of Stéphane Quéré

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Quéré. A scholar is included among the top collaborators of Stéphane Quéré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Quéré. Stéphane Quéré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Astermark, Jan, Susanna Ranta, Stéphane Quéré, et al.. (2025). Health‐Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study. Haemophilia. 31(6). 1271–1282.

Bakri, Sophie J., Winfried M. K. Amoaku, Stéphane Quéré, et al.. (2024). The MOSAIC Study: A Mixed-Methods Study of the Clinical, Emotional, and Financial Burden of Geographic Atrophy Among Patients and Caregivers in the US. Clinical ophthalmology. Volume 18. 2357–2368. 2 indexed citations

Regnault, Antoine, Boris Gorsh, Randy Davis, et al.. (2023). A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies. JNCI Journal of the National Cancer Institute. 115(5). 586–596. 8 indexed citations

Quéré, Stéphane, et al.. (2023). Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis. Journal of Patient-Reported Outcomes. 7(1). 61–61. 5 indexed citations

Halimi, Jean‐Michel, Dominique Joly, Christian Combe, et al.. (2016). Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study. BMC Nephrology. 17(1). 135–135. 10 indexed citations

Joly, Dominique, Gabriel Choukroun, Christian Combe, et al.. (2015). Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: A prospective observational study. Diabetes Research and Clinical Practice. 108(1). 120–127. 6 indexed citations

Rostaing, Lionel, Alexandre Hertig, Laetitia Albano, et al.. (2015). Fibrosis Progression According to Epithelial-Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA. American Journal of Transplantation. 15(5). 1303–1312. 43 indexed citations

Souied, Eric H., et al.. (2015). CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE. Retina. 35(9). 1743–1749. 53 indexed citations

Dejager, S., et al.. (2015). Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study. Vascular Health and Risk Management. 11. 361–361. 38 indexed citations

10.

Dejager, S., Alfred Penfornis, Jean‐Frédéric Blickle, B. Fiquet, & Stéphane Quéré. (2014). How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study. Vascular Health and Risk Management. 10. 341–341. 27 indexed citations

11.

Eschwège, E, C. Attali, J. Bringer, et al.. (2013). Results of the Post-Marketing Survey of Vildagliptin in France. Value in Health. 16(7). A433–A433. 1 indexed citations

12.

Sosner, P., et al.. (2013). How are physicians prescribing the direct renin inhibitor aliskiren in the management of essential hypertension? A French observational study. Journal of Hypertension. 31(7). 1491–1496. 1 indexed citations

13.

Mounier‐Véhier, Claire, Tabassome Simon, Marc Ferrini, et al.. (2012). Gender-related differences in the management of hypertension by cardiologists: The PARITE study. Archives of cardiovascular diseases. 105(5). 271–280. 16 indexed citations

14.

Guerci, Bruno, Louis Monnier, Pierre Sérusclat, et al.. (2012). Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study. Diabetes & Metabolism. 38(4). 359–366. 70 indexed citations

15.

Thierry, Antoine, G. Mourad, M. Büchler, et al.. (2012). Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients. Nephrology Dialysis Transplantation. 27(9). 3651–3659. 8 indexed citations

16.

Penfornis, Alfred, Isabelle Bourdel‐Marchasson, Stéphane Quéré, & S. Dejager. (2012). Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: The HYPOCRAS study. Diabetes & Metabolism. 38(6). 550–557. 17 indexed citations

17.

Simon, D., E Eschwège, Stéphane Quéré, et al.. (2012). PDB13 Interim Results of the Post-Marketing Survey of Vildagliptin in France. Value in Health. 15(7). A495–A495. 1 indexed citations

18.

Cohen, Salomon Y., G. Mimoun, Hassiba Oubraham, et al.. (2012). CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE. Retina. 33(3). 474–481. 166 indexed citations

19.

Kamar, Nassim, Lionel Rostaing, Élisabeth Cassuto, et al.. (2011). A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients. Clinical Nephrology. 77(2). 126–136. 20 indexed citations

20.

Dantal, Jacques, F. Berthoux, Marie‐Christine Moal, et al.. (2010). Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial. Transplant International. 23(11). 1084–1093. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact